Cost-utility analysis of emicizumab prophylaxis in haemophilia A patients with factor VIII inhibitors in Korea

[논문] 이한길, Ah-Young Kim, Deborah Baik, Hyeonseok Cho, Jung Woo Han, Minjun Lee, Seonyoung Park, Hye-Young Kang, Cost-utility analysis of emicizumab prophylaxis in haemophilia A patients with factor VIII inhibitors in Korea , HAEMOPHILIA (Jan, 2021)

논문 링크: https://pubmed.ncbi.nlm.nih.gov/32894895/

DOI: 10.1111/hae.14143